According to the American Cancer Society (ACS), lung cancer is the second most common cancer in men and women, not including skin cancer. This year, the ACS estimates over 200,000 lung cancer cases and over 130,000 deaths due to the disease. Today, smoking is still the leading cause of lung cancer in the U.S. To…
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at…
In July, a working group of 41 prestigious patient advocacy organizations, professional societies, pharmaceutical and diagnostic companies, and laboratories, provided recommendations to fellow healthcare officials for the adoption of consistent, plain language terms for biomarker and genetic testing. The goal of the research is to help eliminate patient confusion about precision testing terminology in oncology.…
A Missouri appeals court ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women who blamed their ovarian cancers on the company’s talcum products, including its iconic baby powder. The decision slashed by more than half a record award of $4.69 billion in compensatory and punitive damages to the women,…
A new study has found that #mesothelioma therapies are underutilized in women. A research team of specialists has uncovered a surprising underutilization of treatments for pleural mesothelioma cancer in women. Women were 15% less likely to receive aggressive mesothelioma surgery that has proven its worth in extending lives for this cancer, which has no definitive cure. They…
It’s 8 a.m. in London and there’s a brisk chill in the springtime air. Rachel Thomas, a lung cancer and mesothelioma clinical nurse specialist at Guy’s Hospital, is just pulling into the employee parking lot of the hospital where she has worked for the past 11 years. She gathers her things from the car and…
Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer. The test has the potential to produce a much-earlier diagnosis of disease and the ability to personalize treatment and better predict a patient’s response to specific therapies.…
Kellogg’s has set a goal of phasing out the controversial weedkiller #glyphosate (used in #Roundup) from its oat and wheat supply chain by 2025, the company confirmed this week. Kellogg’s Chief Sustainability Officer Amy Senter said the company has been working with suppliers on pesticide use since before 2017, and will “continue to actively monitor the science,…
Bayer, which markets the weedkiller Roundup, is in talks to create what might become a $10 billion settlement of tens of thousands of lawsuits claiming that the product causes cancer, a media report says. The company said it would set aside $8 billion to resolve current cases and $2 billion for future claims. The news service…
According to a new study by the BMJ Case Reports, any length or type of exposure to asbestos can cause mesothelioma. No matter if you were exposed to a low quantity or just one instance of exposure, you could be at risk. The study analyzed the case of a pleural mesothelioma patient who had “remote, short-term asbestos…
Fill Out the Form To Receive Yours In The Mail
The safety of our potential clients is a very high priority for us, so we aren’t meeting anyone in-person currently.
If you have a potential case, we will send you out an iPad with all the digital paperwork and we will communicate with you through that iPad. There are also no court appearances required.